Stock Market Cafe
  • Home
  • Trading News
  • Email Whitelisting
  • Privacy Policy
  • Home
  • Trading News
  • Email Whitelisting
  • Privacy Policy
No Result
View All Result
Stock Market Cafe
No Result
View All Result
Home Trading News

Former Theranos patient testifies that blood test at Walgreens came back with false positive for HIV

by
November 18, 2021
in Trading News
0
0
SHARES
0
VIEWS
Share on FacebookShare on Twitter

RELATED POSTS

Stripe tells employees it will decide on an IPO within the next year

The rally that won’t quit says it’s not all about the Fed — listen to Thursday’s ‘Homestretch’

Elizabeth Holmes, founder of Theranos Inc., left, arrives at federal court in San Jose, California, U.S., on Wednesday, Sept. 22, 2021.

Davie Paul Morris | Bloomberg | Getty Images

SAN JOSE, CALIF. – Erin Tompkins, who got her blood drawn from a Theranos device at a Walgreens in Arizona, said the test misdiagnosed her as having an HIV antibody, sending her into a panic.

“I was quite emotional at the time,” Tompkins told jurors on Wednesday in the criminal trial of Theranos founder Elizabeth Holmes.

Tompkins, a witness to the prosecution and the second patient to testify, said she first read about Theranos in Forbes. She later learned more about the blood-testing company on Facebook from a friend who was looking for affordable health-care options.

Holmes is facing 12 counts of wire fraud and conspiracy to commit wire fraud in what federal prosecutors allege is a decade-long scheme to dupe investors and patients about her company’s blood-testing capabilities. Holmes has pleaded not guilty.

Tompkins said she was persuaded by Theranos’ low prices. She told jurors that she asked her doctor to order her a blood test in May 2015. She paid for the test out of pocket because she didn’t have insurance.

“When you decided to go to Theranos for blood testing were you counting on accurate blood test results?” John Bostic, an assistant U.S. attorney, asked of Tompkins.

“Absolutely,” Tompkins said.

“Between cost and accuracy which of those is more important to you?” Bostic asked.

“Well, I think accuracy is most important any time you’re having a medical procedure but cost was a very close second,” Tompkins replied.

Tompkins’ test indicated she had “abnormal results” and pointed to HIV antibodies. Tomkins testified that she had never been diagnosed with HIV or AIDS nor did she ever have any symptoms.

Shortly after getting the results, Tompkins said she called Theranos to speak to someone in the laboratory. Tompkins said she reached a customer service representative who told her she “couldn’t transfer me and that was about it.”

“At any time did you speak to a scientist or a medical professional at Theranos?” Bostic asked.

“No,” Tompkins said.

Three months after the test, Tompkins went to a different clinic to get screened again for HIV. The results came back negative. She was tested again for HIV in August 2021, and received another negative result.

Tompkins’ testimony continues on Thursday.

WATCH: Elizabeth Holmes said she was the ‘ultimate decision maker’ at Theranos

ShareTweetPin

Related Posts

Stripe tells employees it will decide on an IPO within the next year

by
January 26, 2023
0

Stripe co-founder and CEO, Patrick Collison Manuel Blondeau | Getty Images Stripe, the fintech company once valued at $95 billion...

The rally that won’t quit says it’s not all about the Fed — listen to Thursday’s ‘Homestretch’

by
January 26, 2023
0

Jim Cramer says that people just seem to want to own stocks this year. More soft-landing hopes after morning economic...

Tesla’s bounce on quarterly results can teach us something about mega-cap growth names

by
January 26, 2023
0

This is the daily notebook of Mike Santoli, CNBC's senior markets commentator, with ideas about trends, stocks and market statistics....

NBCUniversal expects Peacock losses to peak this year as streamer slowly adds subscribers

by
January 26, 2023
0

In this article CMCSA Follow your favorite stocksCREATE FREE ACCOUNT The NBCUniversal Inc. Peacock streaming service is displayed on a...

Microsoft’s AI push has some analysts raving about the stock even after lackluster earnings

by
January 26, 2023
0

Microsoft 's earnings report earlier this week was largely considered dissatisfying to analysts. But the tech giant's focus on artificial...

Next Post

Macy's earnings top estimates as company lures in new customers, hikes outlook

Alibaba misses expectations as earnings plunge 38% in the September quarter

Leave a Reply Cancel reply

Your email address will not be published. Required fields are marked *

email

Get the daily email about stock.

Please Enter Your Email Address:

By opting in you agree to our Privacy Policy. You also agree to receive emails from us and our affiliates. Remember that you can opt-out any time, we hate spam too!

MOST VIEWED

  • Crocs sees fourth-quarter sales up 42%, CEO Andrew Rees says 2021 was ‘exceptional year’

    0 shares
    Share 0 Tweet 0
  • Biden didn’t accept Putin’s ‘red lines’ on Ukraine – here’s what that means

    0 shares
    Share 0 Tweet 0
  • Buying a car from the factory sounds expensive, but it can actually save you money. Here’s how to do it.

    0 shares
    Share 0 Tweet 0
  • The states that won’t tax military retirement in 2022

    0 shares
    Share 0 Tweet 0
  • Roth TSP vs. Roth IRA: How Do They Compare?

    0 shares
    Share 0 Tweet 0
  • Home
  • Trading News
  • Email Whitelisting
  • Privacy Policy
All rights reserved by www.stockmarket-cafe.com
No Result
View All Result
  • Home
  • Trading News
  • Email Whitelisting
  • Privacy Policy

All rights reserved by www.stockmarket-cafe.com